Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Elke

Elke Bauer, Holzwickede DE

Patent application numberDescriptionPublished
20090308035Optimization of cellular structures especially for exhaust-gas cleaning of combustion assemblies and other fields of application - The invention relates to a device through which a fluid can flow and that has a cellular structure, a system for modular optimization of cellular structures, and also a method for producing such structures.12-17-2009

Elke Bruesehaber, Luebeck DE

Patent application numberDescriptionPublished
20100112662MICROORGANISM FOR PRODUCING RECOMBINANT PIG LIVER ESTERASE - The invention relates to a method for the processing of reaction solutions, containing whole-cell catalysts, an aqueous component and an organic component, wherein the organic component contains the product to be enriched, with the following steps: a) adjustment of the pH value to less than 4; b) filtration of the reaction solution in the presence of a filter aid, preferably in the reaction solution; c) optionally: further enrichment and/or purification of the product contained in the organic component.05-06-2010

Elke Bruesehaber, Greifswald DE

Patent application numberDescriptionPublished
20100021964MICROORGANISM FOR PRODUCING RECOMBINANT PIG LIVER ESTERASE - The present invention relates to a microorganism which comprises at least one copy of a polynucleic acid sequence which is foreign to the host and which encodes a protein having an enzymic activity, and comprises a chaperone system which assists the expression of the protein in the form of an active enzyme, and to a method for producing a protein having esterase activity using such a microorganism.01-28-2010

Elke Brüsehaber, Greifswald DE

Patent application numberDescriptionPublished
20110207186Isoforms of Pig Liver Esterase - The invention relates to novel mutants of γPLE, to vehicles containing the same and to their use in the production of enantiomer-enriched alcohols, carboxylic acids and esters.08-25-2011

Elke Dittrich-Wengenroth, Wuppertal DE

Patent application numberDescriptionPublished
20080255202Phenylthioacetic Acid Derivatives and Use Thereof - The present application relates to novel phenylthioacetic acid derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular disorders, in particular dyslipidaemias and arteriosclerosis.10-16-2008
20080261990Novel Pyrimidine Derivatives and their Use - The present invention relates to novel pyrimidine derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prevention of cardiovascular diseases, in particular dyslipidemias, arteriosclerosis, coronary heart disease, thrombosis and metabolic syndrome.10-23-2008
201001056632-(HETEROARYL) ALKYL INDAZOLE 6-PHENYL AND THIENYL METHYL AMIDE AS THROMBIN INHIBITORS - The invention relates to substituted indazoles and methods for production thereof and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases, especially of cardiovascular diseases, preferably of thromboembolic diseases.04-29-2010
20100184740SUBSTITUTED OXAZOLIDINONES AND THEIR USE - The invention relates to novel substituted oxazolidinones, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.07-22-2010
20100261759SUBSTITUTED OXAZOLIDINONES AND THEIR USE - The invention relates to novel substituted oxazolidinones, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.10-14-2010
20100273789AMINOACYL PRODRUGS - The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-2-oxo-3-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.10-28-2010
20100298293SUBSTITUTED OXAZOLIDINONES AND THEIR USE - The invention relates to novel substituted oxazolidinones, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases, and to the use thereof for producing medicaments for treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.11-25-2010
20110172232AMINOACYL PRODRUGS AS AN ACTIVE PHARMACEUTICAL INGREDIENT FOR THROMBOEMBOLIC DISORDERS - The present application relates to prodrug derivatives of 5-chloro-N-({(5S)-3-[2-fluoro-4-(3-oxomorpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of thromboembolic disorders.07-14-2011

Patent applications by Elke Dittrich-Wengenroth, Wuppertal DE

Elke Duwenig, Ludwigshafen DE

Patent application numberDescriptionPublished
20080209588Expression Cassettes For Seed-Preferential Expression In Plants - The present invention relates to expression cassettes comprising transcription regulating sequences with seed-preferential or seed-specific expression profiles in plants obtainable from 08-28-2008
20090031440Expression Cassettes for Seed-Preferential Expression in Plants - The present invention relates to expression cassettes comprising transcription regulating nucleotide sequences with seed-preferential or seed-specific expression profiles in plants obtainable from the 01-29-2009
20090064374Expression cassettes for seed-preferential expression in plants - The present invention relates to expression cassettes comprising transcription regulating nucleotide sequences with seed-preferential or seed-specific expression profiles in plants obtainable from a tonoplast intrinsic protein gamma 2 gene, preferably from the 03-05-2009
20090241227Expression cassettes for seed-preferential expression in plants - The present invention relates to expression cassettes comprising transcription regulating nucleotide sequences with seed-preferential or seed-specific expression profiles in plants obtainable from 09-24-2009
20090241230Expression cassettes for seed-preferential expression in plants - The present invention relates to expression cassettes comprising transcription regulating nucleotide sequences with seed-preferential or seed-specific expression profiles in plants obtainable from a tonoplast intrinsic protein, said gene being selected from the group consisting of the 09-24-2009

Patent applications by Elke Duwenig, Ludwigshafen DE

Elke Fiebig-Bauer, Iserlohn DE

Patent application numberDescriptionPublished
20090287032METHOD FOR PRODUCING DIENES BY HYDRODIMERIZATION - The invention relates to a process for preparing substituted or unsubstituted 1,7-diolefins by hydrodimerizing non-cyclic olefins having at least two conjugated double bonds in the presence of a reducing agent and of a catalyst, wherein the catalyst used is a metal-carbene complex.11-19-2009
20110152411POLYMER COMPOSITION COMPRISING PHENOLIC RESIN - The invention relates to a polymer composition which is characterized in that it comprises a mixture (A) consisting of formula (A1)) and/or formula (A2), phenolic resin (B) and a stabilizer (C) in the form of a HALS compound06-23-2011
20110207861CONTINUOUS PROCESS FOR PRODUCING A REACTIVE POLYMER - The invention relates to a continuous process for producing a reactive polymer based on compounds according to the structures (A1) and/or (A2) and phenolic resin in an extruder and to the reactive polymer produced according to said process and the use thereof for producing composite materials.08-25-2011

Elke Fritz-Langhals, Ottobrunn DE

Patent application numberDescriptionPublished
20090221842METHOD FOR THE PRODUCTION OF ORGANOSILICON COMPOUNDS COMPRISING CARBOXY RADICALS - Organosilicon compounds bearing carboxylic acid groups are easily and economically replaced in high yield by oxidation of a carbinol-functional organosilicon compound with an oxidizer in the presence of a moderator at a pH≧3. Carboxyl-functional organopolysiloxanes highly useful as textile softeners may be obtained by this method.09-03-2009
20120004436PROCESS FOR THE SYNTHESIS OF 1,3-BIS(AMINOALKYL)DISILOXANES - The invention provides a process for the synthesis of bis(aminoalkyl)disiloxanes of the general formula I by reaction of the carbamatosilanes of the general formula Ma or of the carbamatodisiloxanes of the general formula Mb or of mixtures thereof in the presence of water, where R01-05-2012

Patent applications by Elke Fritz-Langhals, Ottobrunn DE

Elke Gollan, Herne DE

Patent application numberDescriptionPublished
20110251424LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS - The invention relates to low monomer 1:1 monoadducts of reactive olefinic compounds and diisocyanates, to the production and to the use thereof.10-13-2011

Elke Guetlich-Hauk, Lambsheim DE

Patent application numberDescriptionPublished
20110028666PROCESS AND APPARATUS FOR CONTINUOUSLY POLYMERIZING CATIONICALLY POLYMERIZABLE MONOMERS - The present invention relates to a process and to an apparatus for continuous living polymerization of cationically polymerizable monomers, in which at least three feedstocks are mixed in one or more mixers with microstructures and then polymerized in at least one reaction zone.02-03-2011
20110054071METHOD AND DEVICE FOR THE CONTINUOUS PRODUCTION OF POLYMERS BY RADICAL POLYMERIZATION - The present invention relates to a method for the continuous production of a polymer by radical polymerization, wherein at least three materials are mixed with microstructures in one or more mixers and are then polymerized in at least one reaction zone.03-03-2011

Elke Gütlich-Hauk, Lambsheim DE

Patent application numberDescriptionPublished
20110190413PROCESS FOR PREPARING POLYESTERS, ESPECIALLY POLYESTER ALCOHOLS - A process for preparing polyesters by catalytically reacting at least one polyfunctional carboxylic acid or derivative of a polyfunctional carboxylic acid with at least one polyfunctional alcohol.08-04-2011

Elke Haiss, Murg DE

Patent application numberDescriptionPublished
20090054292Encapsulated phthalocyanine granulates - The present invention relates to encapsulated granulates of phthalocyanine compounds wherein the encapsulating layer consists of at least one finely particulate solid and at least one hydrophobic coating material, to a process for the preparation thereof, and to washing agent formulations comprising such granulates.02-26-2009

Patent applications by Elke Haiss, Murg DE

Elke Hartmann, Wuppertal DE

Patent application numberDescriptionPublished
20100136142SUBSTITUTED-4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINAMIDES AND USE THEREOF - The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.06-03-2010
20120022084Substituted 5-fluoro-1H-pyrazolopyridines and their use - The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.01-26-2012

Patent applications by Elke Hartmann, Wuppertal DE

Elke Hellwege, Berlin DE

Patent application numberDescriptionPublished
20080255249Long-Chain Inulin - The invention relates to long-chain inulin and its preparation from artichoke roots, its use in foodstuffs and cosmetic preparations and foodstuffs and cosmetic preparations comprising the long-chain inulin.10-16-2008
20090099129INULIN OF VERY HIGH CHAIN LENGTH - The invention relates to a long-chain inulin and its preparation from artichoke roots, to its use in foodstuffs and cosmetic preparations and to foodstuffs and cosmetic preparations which comprise the long-chain inulin.04-16-2009
20090202705INULIN OF VERY HIGH CHAIN LENGTH - The invention relates to a long-chain inulin and its preparation from artichoke roots, to its use in foodstuffs and cosmetic preparations and to foodstuffs and cosmetic preparations which comprise the long-chain inulin.08-13-2009
20110061131SUGARCANE PLANTS WITH AN INCREASED STORAGE CARBOHYDRATE CONTENT - The present invention relates to a method for increasing the storage carbohydrate content of sugarcane plants.03-10-2011

Patent applications by Elke Hellwege, Berlin DE

Elke Hietschold, Dresden DE

Patent application numberDescriptionPublished
20100040983Compensation of Process-Induced Displacement - A method of manufacturing integrated circuits includes determining a process-induced displacement (e.g., a stress-induced displacement) between primary structures on a substrate and providing a photomask with mask features assigned to the primary structures. The distances between the mask features are set such that the process-induced displacement is compensated.02-18-2010

Elke Horstkotte, Munchen DE

Patent application numberDescriptionPublished
20090221011Coagulation test system - A test element for the determination of coagulation in a plasma or whole blood sample having a first surface (09-03-2009
20100035245Analyte test system using non-enzymatic analyte recognition elements - An analyte test element for the qualitative and/or quantitative determination of at least one analyte in a physiological or aqueous sample fluid having a first surface (02-11-2010

Elke Huthmann, Buchs CH

Patent application numberDescriptionPublished
20110087027SYNTHETIC METHODS FOR SPIRO-OXINDOLE COMPOUNDS - This invention is directed to methods of preparing certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.04-14-2011

Elke Jones, Llano, TX US

Patent application numberDescriptionPublished
20100097635Printer upgrade mechanism - A method for providing computer services is disclosed. The method includes a print server receiving a data file including updates for a printer, parsing the file to acquire one or more update options and defaults for the printer and storing the update options and defaults for the printer in a database.04-22-2010

Elke Kassens, Grabau DE

Patent application numberDescriptionPublished
20110003857STABILIZED, ANTIMICROBIALLY EFFECTIVE COMPOSITION WITH A CONTENT OF BISPYRIDINIUM ALKANE - An aqueous-based composition which includes a) at least one bispyridinium alkane (for example octenidine) and b) at least one stabilizer selected from antioxidants, complexing agents, reducing agents, UV filters and photoprotective agents, in particular α-tocopherol, and BHT. The composition can also include c) one or more auxiliaries selected from, for example, nonionic surfactants, ethers, solvents and polymers, in particular fatty alcohol alkoxylates and alkoxylated fatty acid monoglycerides. The presence of the stabilizer reduces or prevents the appearance of decomposition products of bispyridinium alkanes and, in the case of the presence of auxiliaries, of decomposition products of the auxiliaries, such as ethers and peroxides.01-06-2011
20120004593ANTISEPTIC BASED ON BISPYRIDINIUM ALKANES - An antimicrobially effective composition includes a) at least 0.15% by weight of bispyridinium alkane, b) at least 3.5% by weight of humectant and c) water. Upon dilution with water, the composition produces a solution with an osmolality of from 230 to 350 mOsmol/kg and is free from surfactant. It is used as an antiseptic and is suitable for use in a method for the disinfection of injured or uninjured skin of a human being or animal, preference being given to use in the case of newborns, in particular those born prematurely.01-05-2012

Patent applications by Elke Kassens, Grabau DE

Elke Ladiges, Hepstedt DE

Patent application numberDescriptionPublished
20090039046SUCKER FOR DRINKING PURPOSES - A bottle teat of an elastic material includes a hollow suction nipple and a circumferential mounting edge for fixation to the bottle opening of a drinking bottle. A hollow transition zone is disposed between the mounting edge and suction nipple as well as at least one drinking slot oriented in the longitudinal direction of the suction nipple and extending from the outside up to the inside of the suction nipple in an outwardly bulged external end region of the suction nipple. The bottle teat further includes at least one ventilation valve with a valve slot which is extended from the outer wall of the transition zone up to the inner wall of the transition zone.02-12-2009

Elke Langkopf, Warhausen DE

Patent application numberDescriptionPublished
200802551598-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS - The present invention relates to substituted xanthines of general formula10-16-2008

Elke Langkopf, Biberach An Der Riss DE

Patent application numberDescriptionPublished
20120035158Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions - The present invention relates to substituted xanthines of general formula02-09-2012
20120040982Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions - The present invention relates to substituted xanthines of general formula02-16-2012

Elke Martin, Karlsruhe DE

Patent application numberDescriptionPublished
20080207724Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases - The present invention relates to the medical use of compounds acting as inhibitors of enzymes having histone deacetylase activity in conditions where their combination with compounds known as NSAID's, Non Steroidal Anti Inflammatory Drugs, causes an enhanced beneficial therapeutic effect. These conditions comprise cancer, cancer predisposing conditions, inflammatory and metabolic diseases. Furthermore, the invention includes the manufacture of clinically used medicaments for the therapy of the diseases mentioned herein, administering the compounds separately in the form of two individual drugs or in an administrative form which contains both drugs in a single application unit.08-28-2008
20090088478NOVEL COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS - The present invention relates to compounds as inhibitors of enzymes having histone deacetylase activity, to the processes for the preparation of those compounds, and to their use for the treatment of diseases which are associated with hypoacetylation of histones and/or other molecules, or in which induction of hyperacetylation has a beneficial effect for example by inhibition of proliferation and/or induction of differentiation and/or induction of apoptosis in transformed cells, such as cancer. Furthermore, the compounds are useful for the treatment of other proliferative diseases, for therapy or prophylaxis of conditions associated with abnormal gene expression.04-02-2009
20110092447USING INHIBITORS OF HISTONE DEACETYLASES FOR THE SUPPRESSION THERAPY OF INHERITED DISEASE PREDISPOSING CONDITIONS - Compounds can be used to act as inhibitors of enzymes having histone deacetylase activity for the medical therapy of conditions which predispose a person for the development of a disease, such as but not limited to cancer, inflammatory or metabolic diseases. Such conditions are linked to genetically inherited mutations of crucial genes which predispose a person with this condition to develop the disease phenotype. Thus, such compounds can be used for a suppressive therapeutic approach—the SUPPRESSION THERAPY—in order to inhibit or delay the onset or progression of the genetically predisposed disorder. Furthermore, a clinically used medicament can be manufactured for the SUPPRESSION THERAPY of such inherited predisposing conditions.04-21-2011

Patent applications by Elke Martin, Karlsruhe DE

Elke Muller, Aachen DE

Patent application numberDescriptionPublished
20110150897INFLUENZA TARGETS - The present invention relates to pharmaceutical compositions comprising modulators of kinases, kinase binding polypeptides or/and an inhibitor for influenza virus replication for the prevention or/and treatment of influenza.06-23-2011

Elke Nieter, Holleben DE

Patent application numberDescriptionPublished
20100047353HAIR CARE COMPOSITION - A hair care composition which comprises a plurality of cross-linked polymer particles, said polymer being the polymerization product of at least two monomer units selected from the group consisting of monoalkenyl aromatic compounds, alkyl esters derived from a saturated alcohol and acrylic or methacrylic acid, and vinyl esters of an aliphatic carboxylic acid is useful for controlling sebum on hair without providing undue whiteness to the hair.02-25-2010

Elke Nieter, Hollen DE

Patent application numberDescriptionPublished
20100112021SUSTAINED-RELEASE COMPOSITION - A composition which comprises (A) a plurality of cross-linked polymer particles, said polymer being the polymerization product of at least two monomer units selected from the group consisting of monoalkenyl aromatic compounds, alkyl esters derived from a saturated alcohol and acrylic or methacrylic acid, and vinyl esters of an aliphatic carboxylic acid; and said cross-line polymer particles being loaded with (B) an active ingredient, the weight ratio of the active ingredient (B) to the polymer particles (A) being from 0.05 to 50:1, is useful to release the active ingredient over an extended period of time while controlling sebum on skin and hair.05-06-2010

Elke Osthaus, Gummersbach DE

Patent application numberDescriptionPublished
20090275707PROCESS FOR PREPARING HALOGEN-FREE ATRP PRODUCTS - The present invention relates to the in situ removal of terminal halogen atoms from polymer chains which have been prepared by means of atom transfer radical polymerization, and to the simultaneous removal of transition metals from polymer solutions.11-05-2009

Elke Pachner, Wels AT

Patent application numberDescriptionPublished
20110111243Adhesive Propylene Polymer Composition Suitable for Extrusion Coating of Paper Substrates - Two-component adhesion composition suitable for extrusion coating paper substrates which comprises 05-12-2011
20110229729Adhesive Propylene Polymer Composition Suitable for Extrusion Coating of Paper Substrates - Two-component adhesion composition suitable for extrusion coating paper substrates which comprises a) from 70 to 98 wt % of high melt strength polypropylene (A) with a branching index g′ of 0.9 or less and b) from 2 to 30 wt % of a component (B) selected from the group of (i) maleic anhydride-modified polypropylene (MAPP) (ii) maleic anhydride-modified polypropylene wax (iii) polypropylene homopolymer with high melt flow rate or (iv) ethylene-vinyl acetate-based hot melt adhesive and its use. 09-22-2011

Elke Poppotz, Jena DE

Patent application numberDescriptionPublished
20120063733OPTICAL FIBER, IN PARTICULAR A LASER FIBER CONTAINING A DOPED GLASS FIBER CORE AND CLADDING AROUND THE FIBERGLASS CORE - The invention relates to an optical fiber, in particular a laser fiber, containing a doped glass fiber core (03-15-2012

Elke Reissmüller, Wuppertal DE

Patent application numberDescriptionPublished
20100137361Tetrahydro-Quinolinylurea Derivatives - This invention relates to tetrahydro-quinolinylurea derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations.06-03-2010

Elke Reissmüller, Wuppertal DE

Patent application numberDescriptionPublished
20100137361Tetrahydro-Quinolinylurea Derivatives - This invention relates to tetrahydro-quinolinylurea derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations.06-03-2010

Patent applications by Elke Reissmüller, Wuppertal DE

Elke Rietzel, Darmstadt DE

Patent application numberDescriptionPublished
20090114847PARTICLE THERAPY - The invention relates to a treatment room for a particle therapy system that has a treatment room isocenter, which can be set variably during treatment and forms an origin of a coordinate system, and a patient positioning apparatus for automatically positioning the patient with reference to the set treatment room isocenter.05-07-2009

Elke Roschmann, Corbeil Essonnes FR

Patent application numberDescriptionPublished
20080286765Human Obesity Susceptibility Gene Encoding a Taste Receptor and Uses Thereof - The present invention discloses the identification of a human obesity susceptibility gene, which can be used for the diagnosis, prevention and treatment of obesity and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the TAS1R1 gene on chromosome 1 and certain alleles thereof are related to susceptibility to obesity and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the TAS1R1 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of coronary heart disease and metabolic disorders, including hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, coronary artery disease, diabetes and dyslipidemia.11-20-2008
20090148430HUMAN OBESITY SUSCEPTIBILTY GENE ENCODING POTASSIUM ION CHANNELS AND USES THEREOF - The present invention more particularly discloses the identification of human obesity susceptibility genes, which can be used for the diagnosis, prevention and treatment of obesity ant associated disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses certain alleles of potassium voltage-gated channel (E.CNA) genes related to susceptibility to obesity and representing novel targets for therapeutic intervention. More particularly, the potassium volt-age-gated channel (KCNA) genes are located on chromosome 12 and are selected from the group consisting of KCNA1, KCNA5 and KCNA6. The present invention relates to particular mutations in the KCNA1, KCNA5 and KCNA6 genes and their expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of coronary heart disease and metabolic disorders, including but not limited to hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, coronary artery disease, diabetes and associated complications and dyslipidemia.06-11-2009
20090208482HUMAN OBESITY SUSCEPTIBILITY GENE ENCODING A MEMBER OF THE NEUREXIN FAMILY AND USES THEREOF - The present invention more particularly discloses the identification of a human obesity susceptibility gene, which can be used for the diagnosis, prevention and treatment of obesity and associated disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses certain alleles of the contactin associated protein-like 2 (CNTNAP2) gene related to susceptibility to obesity and representing novel targets for therapeutic intervention. The present invention relates to particular mutations in the CNTNAP2 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of coronary heart disease and metabolic disorders, including but not limited to hypoalphalipoproteinemia, familial combined hyperlipidemia, insulin resistant syndrome X or multiple metabolic disorder, coronary artery disease, diabetes and associated complications and dyslipidemia.08-20-2009

Elke Roschmann, Beimerstetten DE

Patent application numberDescriptionPublished
20080213765Human Autism Susceptibility Genes Encoding a Neurotransmitter Transporter and Uses Thereof - The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the SLC6A1 or SLC6A11 gene on chromosome 3 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the SLC6A1 or SLC6A11 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, childhood disintegrative disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases including schizophrenia.09-04-2008
20090011414HUMAN AUTISM SUSCEPTIBILITY GENE ENCODING A KINASE AND USES THEREOF - The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the MARK1 gene on chromosome 1 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the MARKI gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases including schizophrenia.01-08-2009
20090215040HUMAN AUTISM SUSCEPTIBILITY GENE ENCODING A TRANSMEMBRANE PROTEIN AND USES THEREOF - The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the ATP2B2 gene on chromosome 3 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the ATP2B2 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, childhood disintegrative disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay or language impairment, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases including schizophrenia.08-27-2009

Patent applications by Elke Roschmann, Beimerstetten DE

Elke Rutzinger, Kunten CH

Patent application numberDescriptionPublished
20080199109At Least Two-Layer Label for Opening and Closing Packages and the Use Thereof - An at least two-layer label for opening and closing flexible packages provided with a pre-cut opening closable with a cover, having a base label provided with a first adhesive layer having a weakened cut-off area which is placed over the pre-cut opening, and a covering label whose lower part is provided with a second adhesive layer by which it is adhered to the base label; the adhesive strength of the base label to the package being greater than the adhesive strength of the covering label to the base label.08-21-2008

Elke Schmidt, Bad Sackingen DE

Patent application numberDescriptionPublished
20100199778CAPACITIVE PRESSURE SENSOR - A pressure sensor includes a platform 08-12-2010

Elke Schoeters, Mol BE

Patent application numberDescriptionPublished
20110281018Mycotoxin Binder - A mycotoxin binder is disclosed characterized by 45% or more humic acid, maximum solubility of 20% at pH between 1.5 and 7.0, and an in vitro mycotoxin binding efficiency of at least 80% and preferably 90% with adsorption of at least 85% at pH 3.0 and desorption less than 10% at pH 6.8.11-17-2011

Elke Schubert, Soest DE

Patent application numberDescriptionPublished
20110001312SAFETY BELT - A safety belt includes a length adjuster for securement of one end of a belt webbing, with the length adjuster being constantly biased in a direction of retraction of the belt webbing. A locking mechanism, when rendered effective, inhibits the length adjuster from turning in a direction of protraction of the belt webbing and is operatively connected to a control unit which, when activated, applies a locking function to inhibit the belt member from being pulled out of the retractor and being retracted, thereby preventing a lengthening and shortening of the belt webbing. Operatively connected to the control unit is an actuator which is constructed to allow an occupant, upon actuation, to override the locking function and thereby render the locking mechanism ineffective to enable the occupant to adjust a length of the belt webbing.01-06-2011

Elke Schwiebacher, Simbach DE

Patent application numberDescriptionPublished
20090131591ALKOXYSILANE CROSS-LINKED POLYMERS HAVING IMPROVED ELASTIC RECOVERY PROPERTIES - Moisture curable alkoxysilyl-functional polymers crosslinkable to elastomers having improved recovery properties are prepared by incorporating in the curable composition, both an aminoalkylalkoxysilane and an epoxyalkylalkoxysilane.05-21-2009
20090156737TRANSPARENT POLYMER MIXTURES WHICH CONTAIN ALKOXYSILANE-TERMINATED POLYMERS - Room temperature, moisture curable, transparent, and non-yellowing polymer blends contain at least one alkoxysilyl-terminated polymer bearing an end group06-18-2009

Elke Van Gyseghem, Vilvoorde BE

Patent application numberDescriptionPublished
20100120795POWDERS FOR RECONSTITUTION - This invention relates to powders for reconstitution comprising the NNRTI TMC278 dispersed in certain water-soluble polymers, which can be used in the treatment of HIV infection.05-13-2010

Elke Van Loenhout, Asten NL

Patent application numberDescriptionPublished
20080309915METHOD FOR CORRECTING DISTURBANCES IN A LEVEL SENSOR LIGHT PATH - The invention relates to a level sensor for determining a height of a substrate. The level sensor generates one or more measurement beam and directs the measurement beam to a measurement spot on the substrate and produces a reflected measurement beam. The level sensor also generates one or more reference beams. A detector detects both the reflected measurement beam and the reference beam, respectively, and produces a measurement signal and a reference signal, respectively, the measurement signal being indicative for the height at the measurement spot. A processor that receives these signals and corrects the measurement signal based on the reference signal. The level sensor has an optical arrangement in a predetermined area close to where the substrate is to be located. The measurement beam and the reference beam propagate along substantially equal optical paths of propagation in the predetermined area. The optical arrangement deviates the reference beam from the substantially equal optical paths of propagation in the predetermined area such that the at least one reference beam does not hit the substrate.12-18-2008

Patent applications by Elke Van Loenhout, Asten NL

Elke Wiggeshoff, San Jose, CA US

Patent application numberDescriptionPublished
20090055453DATA ENTRY METHOD AND APPARATUS - On a portable electronic device, multiple-position toggle button data entry keys are provided within the data entry keypad. A controller detects activation of each multiple-position toggle button data entry key on the keypad by a user, and also detects the number of times the data entry key is activated. The controller then accesses a key map in memory to determine the letter or numeric digit selected by the user. All letters and numbers represented on the communication device may be activated with no more than two depressions or activations of a corresponding toggle button.02-26-2009

Elke Zakel, Nauen DE

Patent application numberDescriptionPublished
20110057312CONTACT STRUCTURE AND METHOD FOR PRODUCING A CONTACT STRUCTURE - The invention relates to a contact structure (03-10-2011

Elke Zakel, Falkensee DE

Patent application numberDescriptionPublished
20080210368Method and Device for Transferring a Chip to a Contact Substrate - A method and device for transferring a chip (09-04-2008
20080260370Optical System - Optical system (10-23-2008
20080282574Method and Device For Drying Circuit Substrates - Method and device for drying circuit substrates (11-20-2008
20080302863Method and Device for Transferring a Solder Deposit Configuration - Method and device for transferring a solder deposit configuration having multiple solder deposits onto a terminal surface configuration of a contact surface of a substrate (12-11-2008
20100038348METHOD FOR JOINING ALIGNED DISCRETE OPTICAL ELEMENTS - A method for joining aligned discrete optical elements by which the optical elements can be joined in the aligned state. A thermal connection having long-term stability can be produced at little expense and with high positioning accuracy. Surface regions to be joined can be provided with at least one thin metallic layer by the method for joining aligned discrete optical elements. The surface regions are subsequently wetted using a liquid solder free of flux in a contactless dosed manner. The solder is applied to the surface regions to be joined via a nozzle using a pressurized gas stream.02-18-2010
20100051673METHOD AND DEVICE FOR TRANSFERRING A SOLDER DEPOSIT CONFIGURATION - Method and device for transferring a solder deposit configuration having multiple solder deposits onto a terminal surface configuration of a contact surface of a substrate (03-04-2010
20110244651METHOD AND DEVICE FOR ALTERNATELY CONTACTING TWO WAFERS - A method and device for alternatively contacting two wafer-like component composite arrangements, in which two component composite arrangements, provided with contact metallizations on their opposing contact surfaces, are brought into a coverage position with their contact metallizations to form contact pairs, in which position the contact metallizations to be joined together are pressed against one another, the contact metalllizations being contacted by exposing the rear of one of the component composite arrangements to laser radiation, the wavelength of the laser radiation being selected as a function of the degree of absorption of the component composite arrangement, so that a transmission of the laser radiation through the component composite arrangement exposed to the laser radiation at the rear is essentially suppressed or an absorption of the laser radiation takes place essentially in the contact metallizations of one or both component composite arrangements.10-06-2011

Patent applications by Elke Zakel, Falkensee DE

Elke Zangl, Ellwangen DE

Patent application numberDescriptionPublished
20110086260THIN HOUSING FILM FOR ELECTROCHEMICAL ELEMENTS - A housing film for electrochemical elements includes a barrier layer having a polymeric structure which has been deposited from the gas phase on to a support layer, an electrochemical element which has at least one positive electrode and at least one negative electrode and has at least one such film. A process for producing the electrochemical element includes steps wherein at least two electrodes are applied next to one another on a substrate and are covered with a film, where the substrate and/or the film is such a housing film.04-14-2011